ATE357220T1 - Pharmazeutische zusammensetzung mit modifizierter freisetzung - Google Patents

Pharmazeutische zusammensetzung mit modifizierter freisetzung

Info

Publication number: ATE357220T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; modified release; release pharmaceutical; fraction; allows
Prior art date: 2002-01-09

Application number

AT03701497T

Other languages

English (en)

Inventor

Monique Berwaer

Michel Deleers

Domenico Fanara

Anthony Guichaux

Original Assignee

Ucb Farchim Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-09

Filing date

2003-01-08

Publication date

2007-04-15

2003-01-08 Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa

2007-04-15 Application granted granted Critical

2007-04-15 Publication of ATE357220T1 publication Critical patent/ATE357220T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
BAWMMJAUVBLLEE-UHFFFAOYSA-N 2-[2-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 BAWMMJAUVBLLEE-UHFFFAOYSA-N 0.000 abstract 1
229950003420 efletirizine Drugs 0.000 abstract 1
239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Immunology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT03701497T 2002-01-09 2003-01-08 Pharmazeutische zusammensetzung mit modifizierter freisetzung ATE357220T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02000521		2002-01-09

Publications (1)

Publication Number	Publication Date
ATE357220T1 true ATE357220T1 (de)	2007-04-15

Family

ID=8185210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03701497T ATE357220T1 (de)	2002-01-09	2003-01-08	Pharmazeutische zusammensetzung mit modifizierter freisetzung

Country Status (8)

Country	Link
US (1)	US20050171119A1 (de)
EP (1)	EP1465607B1 (de)
JP (1)	JP2005519053A (de)
AT (1)	ATE357220T1 (de)
AU (1)	AU2003202550A1 (de)
DE (1)	DE60312642T2 (de)
ES (1)	ES2285088T3 (de)
WO (1)	WO2003057198A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1575565E (pt) *	2003-08-08	2010-03-03	Biovail Lab Int Srl	Comprimido de libertação modificada de cloridrato de bupropiona
ES2425762T3 (es) *	2008-10-27	2013-10-17	Roquette Freres	Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
JP2011140510A (ja) *	2011-03-17	2011-07-21	Biovail Lab Inc	塩酸ブプロピオンの放出調節錠剤
JP6184903B2 (ja) *	2014-06-04	2017-08-23	ヴァレアントインターナショナルバミューダＶａｌｅａｎｔＩｎｔｅｒｎａｔｉｏｎａｌＢｅｒｍｕｄａ	塩酸ブプロピオン放出調節錠剤
CA3073866A1 (en)	2017-08-29	2019-03-07	Solural Pharma ApS	Composition comprising suplatast tosilate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3906086A (en) *	1971-07-19	1975-09-16	Richard G Powers	Timed-release aspirin
US4464376A (en) *	1982-07-22	1984-08-07	Richardson-Vicks, Inc.	Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
IE60311B1 (en) *	1987-09-24	1994-06-29	American Home Prod	Sustained release etodolac
IT1215726B (it) *	1988-01-18	1990-02-22	Alfa Wassermann Spa	Formulazioni galeniche a cessione programmata.
US4966147A (en) *	1989-04-24	1990-10-30	Eitan Yaniv	Method for the diagnosis of allergic rhinitis
BE1011045A3 (fr) *	1997-03-14	1999-04-06	Ucb Sa	Compositions pharmaceutiques pour la liberation controlee de substances actives.
US5869479A (en) *	1997-08-14	1999-02-09	Schering Corporation	Treatment of upper airway allergic responses
US6274168B1 (en) *	1999-02-23	2001-08-14	Mylan Pharmaceuticals Inc.	Phenytoin sodium pharmaceutical compositions
EP1118321A1 (de) *	2000-01-14	2001-07-25	Ucb, S.A.	Feste pharmazeutische Zusammensetzungen für die kontrollierte Freisetzung von aktiven Substanzen

2003
- 2003-01-08 AT AT03701497T patent/ATE357220T1/de not_active IP Right Cessation
- 2003-01-08 AU AU2003202550A patent/AU2003202550A1/en not_active Abandoned
- 2003-01-08 WO PCT/EP2003/000093 patent/WO2003057198A1/fr not_active Ceased
- 2003-01-08 ES ES03701497T patent/ES2285088T3/es not_active Expired - Lifetime
- 2003-01-08 JP JP2003557556A patent/JP2005519053A/ja not_active Abandoned
- 2003-01-08 US US10/500,454 patent/US20050171119A1/en not_active Abandoned
- 2003-01-08 EP EP03701497A patent/EP1465607B1/de not_active Expired - Lifetime
- 2003-01-08 DE DE60312642T patent/DE60312642T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60312642D1 (de)	2007-05-03
JP2005519053A (ja)	2005-06-30
WO2003057198A1 (fr)	2003-07-17
US20050171119A1 (en)	2005-08-04
DE60312642T2 (de)	2007-11-29
EP1465607A1 (de)	2004-10-13
EP1465607B1 (de)	2007-03-21
AU2003202550A1 (en)	2003-07-24
ES2285088T3 (es)	2007-11-16

Similar Documents

Publication	Publication Date	Title
BG66093B1 (bg)	2011-04-29	Състави с контролирано освобождаване, съдържащи нимесулид
AR038527A1 (es)	2005-01-19	Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
ITMI20011337A0 (it)	2001-06-26	Composizioni farmaceutiche orali a rilascio modificato del principio attivo
ATE372765T1 (de)	2007-09-15	Feste pharmazeutische formulierungen mit telmisartan
NO330947B1 (no)	2011-08-22	Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
DE60336225D1 (de)	2011-04-14	Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
AR033711A1 (es)	2004-01-07	Composiciones farmaceuticas
DE60205870D1 (de)	2005-10-06	Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
ATE399537T1 (de)	2008-07-15	Pharmazeutische zusammensetzungen mit atorvastatin, hergestellt ohne granulation
TR200401793T4 (tr)	2004-08-23	Perindopril tuzu ve bunu içeren farmasötik bileşimler.
EA200901393A1 (ru)	2010-02-26	Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
AR066924A1 (es)	2009-09-23	Formulacion de nevirapina de liberacion prolongada
ATE327759T1 (de)	2006-06-15	Pharmazeutische zusammensetzung mit verlungerter freisetzung
ATE347358T1 (de)	2006-12-15	Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
BR0112847A (pt)	2003-06-24	Uso de uma forma de dosagem sólida
MXPA06011467A (es)	2007-06-12	Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
BRPI0620229A8 (pt)	2018-01-02	formulação
EA200601759A1 (ru)	2007-04-27	Композиции рамиприла
DE60310526D1 (de)	2007-02-01	Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
ATE410152T1 (de)	2008-10-15	Therapeutisches system mit amoxicillin und clavulansäure
ATE357220T1 (de)	2007-04-15	Pharmazeutische zusammensetzung mit modifizierter freisetzung
HRP20100086T1 (hr)	2010-04-30	(2R,4aR,10bR)-6-(2,6-DIMETOKSIPIRIDIN-3-IL)-9-ETOKSI-8-METOKSI-1,2,3,4,4a,10b-HEKSAHIDROFENANTRIDIN-2-ol, HCI SOL
EA200501565A1 (ru)	2006-06-30	Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
SE0000303D0 (sv)	2000-01-31	Novel compounds
NO20064783L (no)	2006-12-15	Opplosningstabeletter med licarbazepin

Legal Events

Date	Code	Title	Description
2007-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties